Wang Deng

Wang Deng

Auto-generated profile, based on publicly available information

Wang Deng

Department of Respiratory Medicine, Second Affiliated Hospital of Chongqing Medical University, Chongqing, China

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2022 in Oxidative Medicine and Cellular Longevity
Verified
Journal Article
Open access
PDF file
DQDi Qi
Di Qi
WDWang Deng
Wang Deng
XCXiaorui Chen
Xiaorui Chen
SFShulei Fan
Shulei Fan
JPJunnan Peng
Junnan Peng
QYQian Yu
Qian Yu
The “obesity paradox in acute respiratory distress syndrome” (ARDS) refers to the phenomenon in which obesity is associated with higher morbidity but lower mortality in patients with ARDS. Endothelial‐to‐mesenchymal transition (EndMT) represents a key link in the interaction between endothelial disruption and mesenchymal fibrosis under inflammatory and oxidative conditions, which represent the intersectional pathophysiology of ARDS. Adipose tissue is considered to constitute the major source of circulating exosomal microRNAs (miRNAs), which act as genetic forms of adipokines for cell–cell crosstalk. We aimed to demonstrate the regulation and mechanism of adipose‐derived exosomes in the obesity paradox in ARDS. High‐fat‐induced obese mice and lean control mice were subjected to ARDS insult to investigate the effects of obesity on ARDS and microarray analysis was performed to screen for differences in circulating miRNAs. In addition, mice and pulmonary endothelial cells were administered with adipose‐derived exosomal miR‐122‐5p to investigate the underlying molecular mechanisms. We found high‐fat diet‐induced obesity protected against ARDS in mice by reinforcing endothelial barrier and attenuating fibroproliferation. Circulating exosomes produced in the obese state mediated these protective effects by inhibiting EndMT and oxidative stress. Mechanistically, adipose‐derived exosomal miR‐122‐5p promoted the integrity and function of pulmonary endothelial barrier and alleviated fibrogenesis by suppressing EndMT and oxidative stress through down‐regulation of the transforming growth factor β1 (TGF‐β1)/TGF‐β receptor 1 (TGF‐βR1)/Smad2 pathway in vivo and in vitro. In conclusion, adipose‐derived circulating exosomal miR‐122‐5p protects against ARDS by reinforcing pulmonary endothelial barrier through inhibition of EndMT and oxidative stress via down‐regulation of the TGF‐β pathway, which propose a potential explanation for the obesity paradox in ARDS and indicate promising prospects for adipose‐derived exosomes in cell‐free therapies for ARDS.